论文信息 - Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients - 字舞流文

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients

C. Figdor | J. Keunen | C. Punt | N. Naus | A. de Klein | S. Croockewit | W. Gerritsen | K. Bol | E. Kiliç | D. Paridaens | H. Mensink | T. van den Bosch | I. D. de Vries | M. V. van Rossum | K. W. Geul | G. Schreibelt | A. D. de Goede | W. Japing | V. Cohen | W. V. D. van der Graaf | H. Westdorp | J. D. de Vries | S. Boudewijns

[1] C. Figdor,et al. Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination , 2016, Oncoimmunology.

[2] C. Figdor,et al. Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients. , 2014, American journal of ophthalmology.

[3] D. Horsman,et al. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma , 1998, Cancer.

[4] N. Bornfeld,et al. Prognostic implications of monosomy 3 in uveal melanoma , 1996, The Lancet.

[5] N. Schalij-Delfos,et al. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis. , 2006, Investigative ophthalmology & visual science.